Did the resurgence of childhood lower respiratory infections offset the initial benefit of COVID-19-related non-pharmaceutical interventions in children? A time-series analysis
2025
DOI
Copy reference
BMC medicine
Fafi I et al.Fafi I, Assad Z, Lenglart L, Valtuille Z, Kaguelidou F, Aupiais C, Bourmaud A, Rybak A, Bechet S, Levy C, Cohen R, Frandji B, Werner A, Angoulvant F, Basmaci R, Ouldali N
Effectiveness of nirsevimab against RSV-bronchiolitis in paediatric ambulatory care: a test-negative case-control study
2024
The Lancet Regional Health. Europe
Lassoued Y et al.Lassoued Y, Levy C, Werner A, Assad Z, Bechet S, Frandji B, Batard C, Sellam A, Cahn-Sellem F, Fafi I, Lenglart L, Aupiais C, Basmaci R, Cohen R, Ouldali N
Evolution of respiratory syncytial virus burden in young children following the COVID-19 pandemic: influence of concomitant changes in testing practices
The Lancet. Infectious Diseases
Fafi I et al.Fafi I, Assad Z, Lenglart L, Valtuille Z, Ouldali N
